Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. (Q44300036)

1 December 2017

Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. (English)

1 reference

1 December 2017

1 reference

1 reference

Alice H. Lichtenstein

series ordinal

5

object named as

Alice H Lichtenstein

1 reference

1 December 2017

3

Ernst J Schaefer

1 reference

1 December 2017

Nirupa R Matthan

1

1 reference

PubMed ID

12562840

1 December 2017

Ann Giovanni

series ordinal

2

1 reference

PubMed ID

12562840

1 December 2017

B Greg Brown

series ordinal

4

1 reference

1 December 2017

1 February 2003

1 reference

Journal of Lipid Research

1 December 2017

1 reference

1 December 2017

44

1 reference

1 December 2017

4

1 reference

1 December 2017

800-806

1 reference

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Metabolism of beta-sitosterol in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

Antioxidant vitamins and lipid therapy: end of a long romance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200439-JLR200

10.1194/JLR.M200439-JLR200

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12562840